Methylphenidate to Improve Balance and Walking in MS
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
Methylphenidate is an amphetamine-like psychomotor stimulant drug currently approved for the
treatment of attention-deficit hyperactivity disorder (ADHD), postural orthostasis
tachycardia syndrome and narcolepsy. It is also often prescribed off label to people with MS
to improve fatigue. It is proposed that methylphenidate may also improve imbalance and
walking deficits in MS by improving concentration and central integration, one of the primary
mechanisms thought to underlie imbalance and walking deficits in MS.